| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Domain Partners IX, L.P. | 5% | $38,888 | 125,446 | Domain Partners IX, L.P. | 31 Dec 2024 |
As of 30 Sep 2025, 1 institutional investors reported holding 353,212 shares of Singular Genomics Systems, Inc. - Common Stock, $0.0001 par value (OMIC). This represents 14% of the company’s total 2,534,263 outstanding shares.
The largest institutional shareholders of Singular Genomics Systems, Inc. - Common Stock, $0.0001 par value (OMIC) together control 14% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| Virtue Capital Management, LLC | 14% | 353,212 | 0.3% | $1,889,123 |
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q3 | 353,212 | $1,889,123 | +$1,889,119 | $5.35 | 1 |
| 2024 Q2 | 0 | $0 | -$13,052,257 | $5.35 | 0 |
| 2024 Q1 | 25,384,404 | $13,052,261 | -$391,177 | $0.51 | 42 |
| 2023 Q4 | 26,200,325 | $12,085,139 | -$244,372 | $0.46 | 46 |
| 2023 Q3 | 26,403,944 | $10,061,484 | -$3,269,712 | $0.38 | 44 |
| 2023 Q2 | 32,845,333 | $27,285,673 | -$2,629,911 | $0.83 | 59 |
| 2023 Q1 | 35,826,619 | $43,351,241 | -$1,717,858 | $1.21 | 64 |
| 2022 Q4 | 37,188,146 | $74,749,084 | -$3,804,238 | $2.01 | 77 |
| 2022 Q3 | 40,109,923 | $100,279,484 | +$1,123,751 | $2.50 | 66 |
| 2022 Q2 | 38,980,365 | $148,902,312 | -$9,217,261 | $3.82 | 73 |
| 2022 Q1 | 40,969,766 | $258,384,957 | +$11,554,740 | $6.31 | 65 |
| 2021 Q4 | 38,927,034 | $449,992,335 | +$16,835,489 | $11.56 | 61 |
| 2021 Q3 | 27,985,666 | $312,446,188 | -$8,919,642 | $11.19 | 52 |
| 2021 Q2 | 27,563,193 | $757,434,770 | +$757,435,025 | $27.48 | 52 |